Get started
Author

Amit Mukharya

Observed names: A Mukharya, AMIT MUKHARYA
Institution: Amneal (India)
ORCID: 0009-0004-7702-477X
Observed ORCID: 0009-0004-7702-477X
OpenAlex ID: A5007966149
Solid-state characterization of lacidipine/PVP K 29/32 solid dispersion primed by solvent co-evaporation
2012 · Amit Mukharya, Niyaz Mansuri, et al. · International Journal of Pharmaceutical Investigation · 23
Quantitative X-ray fluorescence analysis: Trace level detection of toxic elemental impurities in drug product by ED-XRF spectrometer
2020 · Anirban Roy Chowdhury, Neelesh Maheshwari, et al. · Journal of Pharmaceutical and Biomedical Analysis · 22
Quality risk management of top spray fluidized bed process for antihypertensive drug formulation with control strategy engendered by Box-behnken experimental design space
2013 · Amit Mukharya, PareshU Patel, et al. · International Journal of Pharmaceutical Investigation · 9
Delivery Strategies and Clinical Significance of Oral Colon-targeted Drug Delivery Systems
2026 · Kailash Bansal, Amit Mukharya, et al. · AAPS PharmSciTech · 8
Effect assessment of "film coating and packaging" on the photo-stability of highly photo-labile antihypertensive products
2013 · Amit Mukharya, PareshU Patel, et al. · International Journal of Pharmaceutical Investigation · 8
Characterization of Prednisone Degradants via Forced Degradation Studies: A UHPLC‐Based Approach With HRMS/MS, NMR, and Toxicity Predictions Using Quantitative Structure–Activity Relationship Models
2025 · Ajay Patel, Anirban Roy Chowdhury, et al. · Separation Science Plus · 3
PDF
Evaluation of “In-Use” Stability Period of Lacidipine Tablets in Multi-dose Plastic Container-Closure
2013 · Amit Mukharya, Paresh U Patel, et al. · International Journal of Pharmaceutical Sciences and Nanotechnology · 3
Stable and Bio-equivalent Formulation of HMG-CoA reductase inhibitor: Atorvastatin Calcium
2012 · Amit Mukharya, Shivang Chaudhary, et al. · 3
Development of Novel Single Hplc Method for Simultaneous Separation of Multiple Impurities in Dexamethasone Drug Product
2024 · JIGESH H. SHAH, TUSHAR MEHTA, et al. · International Journal of Pharmacy and Pharmaceutical Sciences · 2
PDF
Functionality advancement of poorly soluble biovariable anti hypertensive Drug by sophisticated SD-FBP technology as per enhanced QbD.
2012 · Amit Mukharya, Shivang Chaudhary, et al. · International Journal of Research and Development in Pharmacy and Life Sciences · 2
Advanced characterization of frovatriptan degradation products using 2D NMR and LC-HRMS/MS: Integrative stability and forced degradation analysis to uncover novel impurities
2025 · Ajay Patel, Anirban Roy Chowdhury, et al. · Microchemical Journal · 1
Gabapentin: An impurity profiling approach with hydrogen peroxide induced thermal oxidation in autoclave
2024 · Anirban Roy Chowdhury, Ajay Patel, et al. · Microchemical Journal · 1
ICP-MS: a tool for detection and quantitation of fosfomycin residues in cleaning samples of finished product by estimation of phosphorous load
2023 · Anirban Roy Chowdhury, Sujal Shah, et al. · Journal of Analytical Atomic Spectrometry · 1
Polymeric ocular drug delivery system for controlled release of norfloxacin. Part 1: In vitro characterization.
1994 · A Mukharya, S K Jain, et al. · PubMed · 1
Recent Innovations in Drug Delivery Systems for Amyotrophic Lateral Sclerosis: Past, Present and Future
2026 · Dhvani P Padhiyar, Shital Butani, et al. · AAPS PharmSciTech
Formulation Development Optimization and Bioavailability Studies of Few Poorly Water Soluble Drugs
2016 · Amit Mukharya · Shodhganga
Functionality Improvement of Gemfibrozil Formulations by QbD Approach
2014 · Amit Mukharya · Journal of Medical Biomedical And Applied Sciences
Product, Process and Packaging Optimization for Development of Stable Oral Capsule Formulation of Second-line Anti- Tubercular drug
2011 · Amit Mukharya, Shivang Chaudhary, et al. · DOAJ (DOAJ: Directory of Open Access Journals)
Works count: 18
Citation count: 87
H-index: 5
I10-index: 2
Year
Topic
Type